318 related articles for article (PubMed ID: 23936344)
1. LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
Greene CJ; Chadwick CM; Mandell LM; Hu JC; O'Hara JM; Brey RN; Mantis NJ; Connell TD
PLoS One; 2013; 8(8):e69678. PubMed ID: 23936344
[TBL] [Abstract][Full Text] [Related]
2. Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens.
Vance DJ; Greene CJ; Rong Y; Mandell LM; Connell TD; Mantis NJ
Clin Vaccine Immunol; 2015 Dec; 22(12):1285-93. PubMed ID: 26491037
[TBL] [Abstract][Full Text] [Related]
3. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
[TBL] [Abstract][Full Text] [Related]
4. Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).
Nawar HF; Berenson CS; Hajishengallis G; Takematsu H; Mandell L; Clare RL; Connell TD
Clin Vaccine Immunol; 2010 Jun; 17(6):969-78. PubMed ID: 20392887
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.
Greene CJ; Hu JC; Vance DJ; Rong Y; Mandell L; King-Lyons N; Masso-Welch P; Mantis NJ; Connell TD
J Leukoc Biol; 2016 Aug; 100(2):361-9. PubMed ID: 27059843
[TBL] [Abstract][Full Text] [Related]
6. Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.
Hu JC; Mathias-Santos C; Greene CJ; King-Lyons ND; Rodrigues JF; Hajishengallis G; Ferreira LC; Connell TD
PLoS One; 2014; 9(12):e113978. PubMed ID: 25536061
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
8. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
9. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
Mathias-Santos C; Rodrigues JF; Sbrogio-Almeida ME; Connell TD; Ferreira LC
Clin Vaccine Immunol; 2011 Aug; 18(8):1243-51. PubMed ID: 21677110
[TBL] [Abstract][Full Text] [Related]
10. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
Alejo DM; Moraes MP; Liao X; Dias CC; Tulman ER; Diaz-San Segundo F; Rood D; Grubman MJ; Silbart LK
Vaccine; 2013 Apr; 31(18):2302-9. PubMed ID: 23499593
[TBL] [Abstract][Full Text] [Related]
11. LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.
Nawar HF; Greene CJ; Lee CH; Mandell LM; Hajishengallis G; Connell TD
Vaccine; 2011 Jan; 29(4):721-7. PubMed ID: 21095251
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
[TBL] [Abstract][Full Text] [Related]
14. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant.
Amorim JH; Diniz MO; Cariri FA; Rodrigues JF; Bizerra RS; Gonçalves AJ; de Barcelos Alves AM; de Souza Ferreira LC
Vaccine; 2012 Jan; 30(5):837-45. PubMed ID: 22178517
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants.
McCluskie MJ; Weeratna RD; Clements JD; Davis HL
Vaccine; 2001 Jun; 19(27):3759-68. PubMed ID: 11395211
[TBL] [Abstract][Full Text] [Related]
17. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
Greene CJ; Marks LR; Hu JC; Reddinger R; Mandell L; Roche-Hakansson H; King-Lyons ND; Connell TD; Hakansson AP
Infect Immun; 2016 Jun; 84(6):1693-1703. PubMed ID: 27001538
[TBL] [Abstract][Full Text] [Related]
18. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.
Lee CH; Masso-Welch P; Hajishengallis G; Connell TD
J Leukoc Biol; 2011 Nov; 90(5):911-21. PubMed ID: 21791597
[TBL] [Abstract][Full Text] [Related]
19. Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine.
Novak H; Doering J; Ehrbar D; Donini O; Mantis NJ
mSphere; 2021 Dec; 6(6):e0075021. PubMed ID: 34730377
[TBL] [Abstract][Full Text] [Related]
20. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
